Simultaneous pembrolizumab-induced myasthenia gravis and myocarditis in a patient with metastatic bladder cancer: A case report

We report a fatal case of pembrolizumab-induced myasthenia gravis and myocarditis in a patient with metastatic bladder cancer. A 77-year-old man was aware of eye ptosis and diplopia after three weeks from first infusion of pembrolizumab, an anti-programmed cell death protein 1 monoclonal antibodies....

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Urol Case Rep
Egile Nagusiak: Takai, Manabu, Kato, Daiki, Iinuma, Koji, Maekawa, Yuka Muramatsu, Nakane, Keita, Tsuchiya, Tomohiro, Yokoi, Shigeaki, Koie, Takuya
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Elsevier 2020
Gaiak:
Oncology
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7068635/
https://ncbi.nlm.nih.gov/pubmed/32190548
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.eucr.2020.101145
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak